tiprankstipranks
Advertisement
Advertisement
Mankind Pharma Schedules Investor Conference Call for Q2 & H1 FY26
PremiumCompany AnnouncementsMankind Pharma Schedules Investor Conference Call for Q2 & H1 FY26
7M ago
Mankind Pharma’s MKP10241 Study: A Potential Game-Changer for Obesity and Diabetes Treatment?
Premium
Company Announcements
Mankind Pharma’s MKP10241 Study: A Potential Game-Changer for Obesity and Diabetes Treatment?
7M ago
Mankind Pharma Reports No Share Dematerialisation Requests for Q3 2025
Premium
Company Announcements
Mankind Pharma Reports No Share Dematerialisation Requests for Q3 2025
8M ago
Mankind Pharma Seeks Reclassification of Promoter Group
PremiumCompany AnnouncementsMankind Pharma Seeks Reclassification of Promoter Group
10M ago
Mankind Pharma to Review Financials and Consider Interim Dividend
Premium
Company Announcements
Mankind Pharma to Review Financials and Consider Interim Dividend
10M ago
Mankind Pharma Schedules Board Meeting to Review Financials and Consider Dividend
Premium
Company Announcements
Mankind Pharma Schedules Board Meeting to Review Financials and Consider Dividend
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100